Correlation Between Phio Pharmaceuticals and Dermata Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Phio Pharmaceuticals and Dermata Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Phio Pharmaceuticals and Dermata Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Phio Pharmaceuticals Corp and Dermata Therapeutics, you can compare the effects of market volatilities on Phio Pharmaceuticals and Dermata Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Phio Pharmaceuticals with a short position of Dermata Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Phio Pharmaceuticals and Dermata Therapeutics.

Diversification Opportunities for Phio Pharmaceuticals and Dermata Therapeutics

0.53
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Phio and Dermata is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Phio Pharmaceuticals Corp and Dermata Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dermata Therapeutics and Phio Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Phio Pharmaceuticals Corp are associated (or correlated) with Dermata Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dermata Therapeutics has no effect on the direction of Phio Pharmaceuticals i.e., Phio Pharmaceuticals and Dermata Therapeutics go up and down completely randomly.

Pair Corralation between Phio Pharmaceuticals and Dermata Therapeutics

Given the investment horizon of 90 days Phio Pharmaceuticals Corp is expected to under-perform the Dermata Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Phio Pharmaceuticals Corp is 2.22 times less risky than Dermata Therapeutics. The stock trades about -0.1 of its potential returns per unit of risk. The Dermata Therapeutics is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest  327.00  in Dermata Therapeutics on August 24, 2024 and sell it today you would lose (212.00) from holding Dermata Therapeutics or give up 64.83% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Phio Pharmaceuticals Corp  vs.  Dermata Therapeutics

 Performance 
       Timeline  
Phio Pharmaceuticals Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Phio Pharmaceuticals Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's forward indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.
Dermata Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Dermata Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's primary indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Phio Pharmaceuticals and Dermata Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Phio Pharmaceuticals and Dermata Therapeutics

The main advantage of trading using opposite Phio Pharmaceuticals and Dermata Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Phio Pharmaceuticals position performs unexpectedly, Dermata Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dermata Therapeutics will offset losses from the drop in Dermata Therapeutics' long position.
The idea behind Phio Pharmaceuticals Corp and Dermata Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios